Perspectives on reasons of medication nonadherence in psychiatric patients

Patient Preference and Adherence

Volumn 9, Issue , 2015, Pages 87-93

  Mert, Derya Güliz ^a   Turgut, Nergiz Hacer ^a   Kelleci, Meral ^a   Semiz, Murat ^b  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Bipolar disorder; Depression; Patient s attitude; Schizoaffective disorder; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DRUG USE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; MENTAL DISEASE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT CODING; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SOCIAL ASPECT; SYNDROME DELINEATION; TREATMENT REFUSAL;

EID: 84921444953     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S75013     Document Type: Article

References (27)

1. Crowe M, Wilson L, Inder M. Patients' reports of the factors influencing medication adherence in bipolar disorder - an integrative review of the literature. Int J Nurs Stud. 2011;48(7):894-903.
2. Chapman SC, Horne R. Medication nonadherence and psychiatry. Curr Opin Psychiatry. 2013;26(5):446-452.
3. Patel MX, David AS. Medication adherence: predictive factors and enhancement strategies. Psychiatry. 2007;6(9):357-361.
4. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002;159(10):1653-1664.
5. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002;63(5):384-390.
6. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry. 2002;180:104-109.
7. Kelleci M, Ata EE. Psikiyatri Kliniği'nde Yatan Hastaların ilaç Uyumları ve Sosyal Destekle İlişkisi. [Drug compliance of patients hospitalized in the psychiatry clinic and the relationship with social support]. J Psy Nurs. 2011;2(3):105-110. Turkish [with English abstract].
8. Yilmaz S, Buzlu S. Antipsikotik kullanan hastalarda ilaç yan etkileri ve ilaç uyumu. [Side effects of medications and adherence to medication in patients using antipsychotics]. İ Ü F N Hem Derg. 2012;20(2):93-103. Turkish [with English abstract].
9. Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry. 2012;12:87.
10. Breen R, Thornhill JT. Noncompliance with medication for psychiatric disorders. CNS Drugs. 1998;9(6):457-471.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 5th ed. Arlington, VA: American Psychiatric Association; 2013:726-727.
12. Sin J, Gamble C. Managing side-effects to the optimum: valuing a client's experience. J Psychiatr Ment Health Nurs. 2003;10(2):147-153.
13. Sarandol A, Akkaya C, Cangur S, Mercan S, Pirinççi E, Kirli S. Ayaktan takip edilen şizofreni hastalarının takip sürelerini etkileyen sosyodemografik, hastalık ve tedaviye ait özellikler. [Sociodemographic, disorder and treatment related characteristics affecting follow-up periods of schizophrenic outpatients]. Klinik Psikofarmakoloji Bülteni. 2007;17(1):15-23. Turkish [with English abstract].
14. First MB, Gibbon M, Spitzer RL, Williams JB. SCID-I. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York, NY: Biometrics Research; 2001.
15. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000;51(2):216-222.
16. Coodin S, Staley D, Cortens B, Desrochers R, McLandress S. Patient factors associated with missed appointments in persons with schizophrenia. Can J Psychiatry. 2004;49(2):145-148.
17. Arvilommi P, Suominen K, Mantere O, Leppämäki S, Valtonen H, Isometsä E. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study. J Affect Disord. 2014;155:110-117.
18. Leclerc E, Mansur RB, Brietzke E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord. 2013;149(1-3):247-252.
19. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892-909.
20. Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas. 2014;5:43-62.
21. Javadpour A, Hedayati A, Dehbozorgi GR, Azizi A. The impact of a simple individual psycho-education program on quality of life, rate of relapse and medication adherence in bipolar disorder patients. Asian J Psychiatr. 2013;6(3):208-213.
22. Unal S, Cakır G, Elyas Z. Taburculuk sonrası tedaviye gelmeyen psikotik hastaların özellikleri. [Characteristics of psychotic patients don't come to appointments]. Anadolu Psikiyatri Dergisi. 2006;7:69-75. Turkish [with English abstract].
23. Tel H, Doğan S, Özkan B, Çoban S. Compliance to treatment among chronic psychiatric disorder patients according to their relatives. Psikiyatri Hemşireliği Dergisi. 2010;1(1):7-12.
24. Nageotte C, Sullivan G, Duan N, Camp PL. Medication compliance among the seriously mentally ill in a public mental health system. Soc Psychiatry Psychiatr Epidemiol. 1997;32(2):49-56.
25. McEvoy JP, Apperson LJ, Appelbaum PS, et al. Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis. 1989;177(1):43-47.
26. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry. 1998;172:413-419.
27. Kelly GR, Scott JE, Mamon J. Medication compliance and health education among outpatients with chronic mental disorders. Med Care. 1990;28(12):1181-1197.